• BG IRIS Research Client Login
logo
logo
  • Transactions
  • Services
    • Overview
    • Solutions
    • Sector expertise
    • Research
  • Insights
    • Overview
    • White Papers
    • Blog
    • Reports
    • Client Focus
  • About us
    • Overview
    • Senior Team
    • News
    • Events
  • Careers
    • Overview
    • Early careers
    • Experienced hires
    • Employee Growth Stories
  • Media
    • Press
    • Videos
  • Contact
  • Search
  • BG IRIS Research Client Login

Solutions


From raising venture capital to taking companies public, supporting acquisition strategies to advising management buy-outs or finding strategic partners, Bryan Garnier supports clients and their investors at every stage of their growth and investing journeys.​ Bryan Garnier’s holistic approach to advising clients on the full range of equity, debt and M&A transactions creates a true client-first model, building long-term relationships over the full business lifecycle.

M&A Advisory


Private Capital Solutions


Debt Solutions

Public Capital Solutions


Institutional Sales and Trading

Hide filtersShow filters
× Close

Sectors

  • (218)
  • (177)
  • (106)
  • (96)
  • (48)

Deal Type

  • (298)
  • (141)
  • (141)
  • (7)

Clear all Apply

Bryan, Garnier & Co acts as Sole Financial Advisor to SmartMeUp on its sale to Magneti Marelli

SmartMeUp tomstone

Einride Bridge Loan

Einride_tombstone_oct18

Bryan, Garnier & Co advises Latour Capital on the acquisition of a majority stake in Sogetrel

Latour tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Montagu Private Equity on the acquisition of Maincare Solutions

Maincare Solutions tombstone

Bryan, Garnier & Co acts as Financial Advisor to Blueberry Therapeutics on its £10 million Series B Fundraising

Blueberry Therapeutics tombstone

Advania, 30% investment by VIA Equity & PFA

Advania_tombstone_sept18

80% of Kippr acquired by ECIT AS

Kippr_tombstone_aug18

MakeIt Drift as acquired by Procano AS

Make it drift as _tombstone_aug18

Bryan, Garnier & Co acts as Joint Bookrunner on Materialise’s USD45 million Follow–On Equity Offering on Nasdaq

Materialise tombstone

Bryan, Garnier & Co advises TxCell in its strategic review and subsequent EUR72 million sale to Sangamo Therapeutics to create a CAR-Treg leader

TxCell tombstone

Bryan, Garnier & Co acts as Sole Bookrunner on ASIT biotech EUR12 million Convertible Bond Placement

ASIT biotech tombstone

Bryan, Garnier & Co advises Marquetis & Co and its management on a sponsorless operation with Omnes

Marquetis tombstone
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 50

Bryan, Garnier & Co

Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors.

CONTACT US
Latest News

  • BCI – Made in France 2025 – Hosted by Bryan, Garnier & Co
  • The Next Launch Window: What It Means for Satcoms
  • BG Growth Series – Avantium
  • Energy-Aware AI: Confronting the power-hungry reality of scaling AI
Quick links

Transactions

Insights

Senior Team

Information

Legal & Regulatory Information

Index 2025

Bryan Garnier Securities

Privacy Policy

Privacy Preference Center

Privacy Preferences

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }